Amira Medical Receives FDA Clearance to Market New Blood Glucose Testing Device
The Food and Drug Administration has given market clearance to Amira Medical to sell its AtLastTM Blood Glucose System. The AtLast system is designed to obtain blood samples from the forearm, thigh, or upper arm, areas which have fewer nerve endings than fingertips. The company believes that the AtLast system is less painful to use than traditional fingertip lancets.
The AtLast system contains both the lancing device and the blood glucose meter, making it an "all-in-one" product. The system will be sold at prices comparable to meters and test strips already on the market and will be available via mail order in the second quarter of 1999.
For additional information, contact:
4742 Scotts Valley Drive
Scotts Valley, CA 95066
(408) 439-0700 Phone
(408) 439-1744 Fax
The AtLast Blood Glucose System in use. Click to see a larger image.
Posted 31 January 1999
Last Updated: Thursday February 27, 2014 19:28:21
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.